SD Biosensor Inc
KRX:137310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SD Biosensor Inc
Net Income
SD Biosensor Inc
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SD Biosensor Inc
KRX:137310
|
Net Income
-₩98.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Net Income
₩47.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Net Income
₩17.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Net Income
-₩235.4B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Net Income
₩46.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Net Income
₩12.9B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
SD Biosensor Inc
Glance View
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2021-07-16. The firm is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The firm is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is SD Biosensor Inc's Net Income?
Net Income
-98.1B
KRW
Based on the financial report for Dec 31, 2024, SD Biosensor Inc's Net Income amounts to -98.1B KRW.
What is SD Biosensor Inc's Net Income growth rate?
Net Income CAGR 1Y
79%
Over the last year, the Net Income growth was 79%.
